BioAge Labs, Inc. announced its participation in the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, 2026. CEO and co-founder Kristen Fortney, PhD, will join a fireside chat, and both Fortney and CFO Dov Goldstein, MD, will hold one-on-one meetings. The company is a clinical-stage biotechnology firm focused on developing therapeutic candidates for metabolic diseases by targeting human aging.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
BioAge Labs, Inc. announced its participation in the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, 2026. CEO and co-founder Kristen Fortney, PhD, will join a fireside chat, and both Fortney and CFO Dov Goldstein, MD, will hold one-on-one meetings. The company is a clinical-stage biotechnology firm focused on developing therapeutic candidates for metabolic diseases by targeting human aging.